Trials / Sponsors / Xenothera SAS
Xenothera SAS
Industry · 5 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Polyspecific Antibodies in Lymphoproliferative T-cell Disorders Peripheral T Cells Lymphoma (PTCL) | Phase 1 / Phase 2 | 2024-07-09 |
| Recruiting | FIH XON7 in Advanced/Metastatic Solid Tumors Advanced Solid Tumor, Metastatic Cancer | Phase 1 / Phase 2 | 2023-11-14 |
| Completed | A First-in-Human Study With XAB05 in Healthy Subjects Infection, Bacterial | Phase 1 | 2022-01-24 |
| Terminated | Efficacy and Safety of XAV-19 for the Treatment of Moderate-to-severe COVID-19 COVID-19 | Phase 2 / Phase 3 | 2021-04-28 |
| Completed | First in Human Study: LIS1, an Induction Treatment in Kidney Transplanted Patients Kidney Transplant | Phase 1 / Phase 2 | 2019-11-26 |